Spranger et al. revealed that upregulation of the oncogenic β-catenin pathway suppressed the production of crucial chemokine CCL4 and subsequently prevented recruitment of intratumoral CD103+ DCs, followed by diminishing T lymphocytes in melanomas (Spranger et al., 2015). The gene discussed is CCL4; the disease is melanoma.